Search results
How to Safely Discontinue Multiple Myeloma Maintenance Care
Medscape· 2 days agoNew research suggested that the key to safely discontinuing multiple myeloma maintenance therapy is...
ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory...
Morningstar· 2 days agoPfizer Inc. (NYSE: PFE) today announced detailed overall survival (OS) results from the Phase 2 MagnetisMM-3 study of ELREXFIO™ (elranatamab-bcmm) in patients with heavily pretreated relapsed ...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
Live Science via Yahoo News· 2 days agoNew England Journal of Medicine, provides important insight into secondary cancers that may arise...
Touched by cancer: Todd Riley will host a fundraiser and ride in this year's Pelotonia.
Times Recorder via Yahoo News· 3 days ago“That’s what motivates me to keep doing this.” Riley saw a 2018 article for Pelotonia about its 10th...
CAR-T cell therapy to treat blood cancers unlikely to increase risk of secondary cancers
United Press International via Yahoo News· 2 days agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that...
2024 Warren Alpert Foundation Prize Honors Four Pi | Newswise
Newswise· 5 days agoThe 2024 Warren Alpert Foundation Prize has been awarded to four scientists whose transformational discoveries led to the creation of chimeric antigen receptor (CAR) T cells, a treatment that ...
Case study reveals important new details about rare second cancers related to CAR-T therapy
Medical Xpress· 3 days agoA new detailed analysis of a patient's second cancer after receiving CAR-T therapy for the initial cancer provides rare but important insights intended ...
New cancer treatment increases efficacy by injecting chemo directly into tumor cells
BGR· 6 days agoChemotherapy has proven to be a fairly successful treatment for cancer. The Food and Drug...
Immix Biopharma CFO buys $5.3k in company stock By Investing.com
Investing.com· 5 days agoGabriel S. Morris, the Chief Financial Officer (CFO) of Immix Biopharma, Inc. (NASDAQ:IMMX), has...
Cardiovascular conditions now the second-highest reimbursement category, Sun Life says
HR Dive· 2 days agoCardiovascular conditions — including congenital heart defects, heart failure, stroke and hypertension — moved into the second spot for stop-loss reimbursements in 2023 for the first time, an ...